Recent Grant Funding at Texas Children’s Cancer & Hematology Center

Texas Children’s Cancer & Hematology Center is proud to celebrate faculty who have recently secured competitive research grants totaling more than $3.4 million. These awards will advance innovation in immunotherapy and genomics, reduce disparities in leukemia care, and strengthen multidisciplinary training in blood disorders—ultimately improving outcomes for children and adolescents with cancer and blood disorders.

The following Principal Investigators and projects were recently awarded funding (pictured above, left to right by row):

• Alison A. Bertuch, MD, PhD
  Houston Area Incubator for Kidney, Urologic, and Hematologic Research Training (HAI-KUH)
  Funding Agency: National Institutes of Health (NIH)
• Ahmed Gad, PhD
  Tuning Chimeric Antigen Receptor T Cell Activity in Brain Cancer Patients
  Funding Agency: American Brain Tumor Association
• Marco Gallo, PhD
  Targeting Core Malignant Programs in Pediatric High-Grade Gliomas
  Funding Agency: Alex’s Lemonade Stand Foundation
• Maria Monica Gramatges, MD, PhD
  Reducing Ethnic Disparities in AML (REDIAL)
  Funding Agencies: National Cancer Institute (U54 SPORE) & National Institutes of Health
• Michele S. Redell, MD, PhD
  Better Monitoring for Better Outcomes in Pediatric AML
  Funding Agency: Leukemia Texas
• Eric S. Schafer, MD, MHS
  Research Specialist (Clinician Scientist) Award
  Funding Agency: National Cancer Institute (NCI)

We thank these funding agencies and our dedicated faculty for their commitment to advancing care and research for young patients. Their work exemplifies Texas Children’s mission to lead in pediatric cancer and hematology innovation.